MetaStat Inc Sustainability Reports

MetaStat, Inc. is a precision medicine biotechnology company focused on discovering and developing therapeutic and diagnostic treatment solutions for cancer patients. The company specifically develops small molecule and peptide-based kinase inhibitors targeting the Mena-dependent metastatic cascade.

Sector: Manufacturing

Country: United States

Exchange: OTC Markets

FIGI: BBG001SRW680

No reports are currently available in our catalogue.